United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 5 minute read Technology Industry News Axon to acquire Carbyne for $625m to revolutionize next-gen 911 with cloud and AI integration Find out how Axon’s $625 million acquisition of Carbyne aims to reinvent 911 through cloud-powered AI integration and connected emergency response. bySoujanya RaviNovember 5, 2025